Translational Genomics, a journal of the Company of Scientists, is dedicated to publishing scientific advances in genomics and other omics technologies and its application in medicine. Areas covered by the journal include, but are not limited to precision medicine, genome informatics, systems medicine, genomics for diagnosis of genetic diseases, cancer genomics, population genetics, clinical epigenomics, modeling diseases, pathogen genomics and microbiome studies with clinical relevance and novel genomic technologies, assays, software or methodologies.

Translational Genomics (TG) journal invites authors to contribute their articles. The online system is open for submission. TG is dedicated to publishing scientific advances in genomics and other omics technologies and its application in medicine. Areas covered by the journal include, but are not limited to precision medicine, genome informatics, systems medicine, genomics for diagnosis of genetic diseases, cancer genomics, population genetics, clinical epigenomics, modeling diseases, pathogen genomics and microbiome studies with clinical relevance and novel genomic technologies, assays, software or methodologies.

Read more


c19genomics_tg.png

In light of the urgent necessity for peer-reviewed research, especially in the area of genomics and biology of COVID-19, Translational Genomics is announcing a new policy aimed at speeding up the dissemination of this vital science. All COVID-19 submissions would also undergo a fast-track review. 

 

 

Read more